RS

Rajeev Singh

Director Additional Director DIN 02786161
DIN 02786161 First appointment Mar 2014 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2014
Shareholding value Locked Premium profile

About Rajeev Singh

Rajeev Singh has 12 years in corporate governance. Holds Additional Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 02786161
Primary Designation Additional Director
First Appointment 04 Mar 2014
Oldest Company Age 12 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Hiero Bioscience Limited U24233UR2013PLC000868
Additional Director 04 Mar 2014 2013 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hiero Bioscience Limited
Premium access

Shareholding and investment profile for Rajeev Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Singh

Rajeev Singh has 12 years in corporate governance. Holds Additional Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Rajeev Singh is associated with 0 companies as Additional Director.

Rajeev Singh has expertise in General Business.

Rajeev Singh has 12 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available